Use of Medicines

As the world is figuring out how to deal with COVID-19, it is worth taking stock of the broader value that existing vaccines bring to societies suffering from this pandemic. We illustrate this broader value by considering how existing vaccines can help protect people from other respiratory conditions or from COVID-19 co-infections and relieve overburdened healthcare systems.

OHE Lunchtime Seminar with Alistair McGuire, 3rd February 2020. The seminar will present some preliminary thoughts on the promises offered by personalised medicine that it will allow efficient identification of different target groups and consequently more effective treatment.

OHE Consulting produces a report on Measuring UK Medicines Expenditure in the Context of the 2014-18 PPRS.

OHE has just published a new briefing entitled ‘Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help?’

OHE publishes a report assessing the capacity in South Korea for the collection and use of real-world data in health care.

A new OHE Consulting Report assesses information governance arrangements for real-world data in eight countries, and makes recommendations towards an ideal governance framework.

A new OHE Consulting Report considers the data capabilities in the UK for monitoring medicine use according to indication using real world data.

September 2014 ABPI report of OHE analysis: UK use of medicines compared with other countries – UK remains 9th highest user out of 13 countries.